BS

Badri Saini

Active Director Director DIN 07415474
DIN 07415474 First appointment Feb 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Badri Saini

Data last updated:

Badri Saini is a Director at Aayurmax Pharma Private Limited (since 2016). The company operates in Pharma. Aayurmax Pharma Private Limited reported revenue of ₹30.2 Lakh (FY 2020).

DIN 07415474
Primary Designation Director
Industry Pharma
First Appointment 29 Feb 2016
Oldest Company Age 10 yrs
Largest company Aayurmax Pharma Private Limited · ₹30.2 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aayurmax Pharma Private Limited U24232RJ2016PTC049448
Director29 Feb 20162016₹30.2 Lakh (FY 2020)Active

Board colleagues of Badri Saini

NameDINCompanyDesignation
Kamla Devi09623998Aayurmax Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aayurmax Pharma Private Limited
Premium access

Shareholding and investment profile for Badri Saini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Badri Saini

Badri Saini currently holds 1 directorship: Aayurmax Pharma Private Limited (Director, since 29 Feb 2016, revenue ₹30.2 Lakh (FY 2020)).

Badri Saini was first appointed on 29 Feb 2016 as Director at Aayurmax Pharma Private Limited.

The current boards of Badri Saini's companies include Kamla Devi (Aayurmax Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available